Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes

February 27, 2025

American Bar Association 2025 Asia-Pacific Conference

On February 28, Axinn partner Tiffany Rider will speak on the "Ready for a Dawn Raid in the Digital Era?" panel at the American Bar Association's Asia-Pacific Conference, being held February 26-28 in Singapore.

Speaking Engagement

Antitrust

February 20, 2025

NBA Commercial Law Section 38th Annual Corporate Counsel Conference

Axinn is pleased to announce its sponsorship of the National Bar Association Commercial Law Section's Corporate Counsel Conference, being held February 20-22 in Fajardo, Puerto Rico.

Sponsorship

Antitrust

January 30, 2025

GCR Live: Law Leaders Global 2025

On January 30, Axinn partner Bradley Justus will speak on the "Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe" panel at Global Competition Review's Law Leaders Global Conference, being held January 29-31 in Miami.

Speaking Engagement

Antitrust

January 29, 2025

The 32nd Annual Marketing Partner Forum

Chief marketing and business development officer Julie Chodos will moderate the "Skilled Artisans: Ensuring Cross-Team Communication and Accountability between Lawyers and Marketing Teams" panel at Thomson Reuters' 32nd Annual Marketing Partner Forum being held in Sonoma, California on January 29th to 31st.

Event

January 26, 2025

SABA North America Corporate Counsel Retreat 2025

Axinn is pleased to announce its sponsorship of the South Asian Bar Association of North America’s Corporate Counsel Retreat, being held January 26-28 in Charlotte, North Carolina.

Sponsorship

Antitrust

January 13, 2025

Axinn Antitrust Insight: FTC Announces Revised HSR Thresholds for 2025

What You Need to Know

Client Alerts

Antitrust

January 13, 2025

Four Axinn Thought Leadership Pieces Nominated for the Antitrust Writing Awards

Four written pieces authored by Axinn lawyers have been nominated for the Concurrences 2025 Antitrust Writing Awards. These awards aim to promote competition scholarship and contribute to competition advocacy. Axinn’s lawyers have consistently been recognized in previous nominations over the years.

Awards & Recognitions

Antitrust

January 10, 2025

Merger Remedies Back in Vogue Under Trump

Axinn partner and chief diversity, equity & inclusion officer Leslie Overton was quoted in The Deal article, "Merger Remedies Back in Vogue Under Trump.

Media Mentions

Antitrust

January 10, 2025

Three Takeaways from the Initial Determination at the ITC Regarding Standard Essential Patents in the 1380 Investigation

On January 8, 2025, Administrative Law Judge (ALJ) Cameron Elliot issued a public version of the Initial Determination (ID) in Certain...

Axinn Viewpoints

Intellectual Property

January 9, 2025

A POSA’s Motivation Is Not Required To Be the Same as the Inventor’s in Evaluating Obviousness

In its first precedential opinion of 2025, Honeywell v. 3G Licensing, No. 2023-1354, the Federal Circuit held that a person of ordinary...

Axinn Viewpoints

Intellectual Property

January 9, 2025

Axinn Attorneys Complete Federal Bar Association's StepUp Pro Bono Challenge

Associates Ian Swan and Don Z. Wang 王哲楠 were two of the eight attorneys recognized in FBA Young Lawyers Division’s annual StepUp Pro Bono Challenge, which recognizes pro bono work for nonprofit organizations or low-income individuals completed between October 1, 2023, and September 30, 2024.

Pro Bono

January 6, 2025

Will the Past Be the Future? Looking Back at 2024 and Forward to 2025

Partner James Hunsberger appeared, along with Alicia Downey (Downey Law), Anora Wang (Arnold & Porter ), Brendan Coffman (Wilson Sonsini), Matthew Hall (McGuireWoods), and Derek Jackson (Cohen & Gresser), on "Our Curious Amalgam," the ABA's Antitrust podcast, to discuss 2024's notable developments and trends and insights regarding the emerging topics and themes of the coming year.

Podcast

Older Patents Get Help As Federal Circuit Sides With Novartis In Gilenya, Everolimus Disputes

Related People

Related Services

Featured Insights

Featured Insights